Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIARA method for timed anesthesia reversal in transfemoral TAVI
jRCT1021250019Active, not recruiting
- Start
- Sep 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of remimazolam and flumazenil in aortic stenosis (AS) (2 arms). Primary endpoint: Proportion of patients extubated at the target timing. Started Sep 2025; status: active, not recruiting.
02
Drugs
remimazolamflumazenil
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on jRCT1021250019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1021250019.